Results 201 to 210 of about 665,294 (217)

High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy

Annals of Oncology, 2012
Béatrice Bouvard, E Legrand, E Hoppe
exaly  

Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer

Annals of Oncology, 2013
Mitch Dowsett, R A'Hern, J Salter
exaly  

Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors

Breast, 2020
Sally A D Romero, Jaya M Satagopan
exaly  

Aromatase inhibitor regulates let-7 expression and let-7f–induced cell migration in endometrial cells from women with endometriosis

Fertility and Sterility, 2016
Hugh S. Taylor, SiHyun Cho, Levent Mutlu
exaly  

Predictors of recovery of ovarian function during aromatase inhibitor therapy

Annals of Oncology, 2013
R Xia, N L Henry, N L Henry
exaly  

Persistent bilateral ureteral obstruction secondary to endometriosis despite treatment with an aromatase inhibitor

Fertility and Sterility, 2008
Chi Chiung Grace Chen
exaly  

Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options

Supportive Care in Cancer, 2015
Nicholas Zdenkowski, John Douglas Forbes
exaly  

A bovine model for examining the effects of an aromatase inhibitor on ovarian function in women

Fertility and Sterility, 2011
Jaswant Singh, Jimena Yapura, John P. Giesy   +2 more
exaly  

Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer†

Ca-A Cancer Journal for Clinicians, 2005
Ruth M O'Regan, R M O'Regan
exaly  

Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation

American Journal of Obstetrics and Gynecology, 2005
Robert Casper
exaly